-
NICE decision a blow to accessing cannabis for MS
‘Today the National Institute for Health and Care Excellence (NICE – the main UK regulatory body for licensing drugs for the NHS) has ‘published draft guidance for prescribing cannabis-based medicines. It’s refused to recommend cannabis for pain and spasticity in MS, and won’t recommend Sativex for wider use on the NHS.
I’ve written below that Sativex isn’t a great loss (it costs circa £500 a month – the real thing is far, far cheaper) but despite cannabis being licensed for some patients – there seem to be none to in the MS community.
So many of us are thrown into the grey world of illegality. For me this is nothing new but if you’re strictly law abiding and have MS do you grin & bear it?
What do you think?
-
0 Replies
Sorry, there were no replies found.
Log in to reply.